EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Organotypic Patient-Derived Ovarian Tumor Extracellular Matrix Hydrogel for Biomimetic 3D Cancer Modeling

Francesca Sensi, Edoardo D’Angelo, Caterina Franchi, Astrid Alexa Mollo Castillo, Angela Guerriero, Monica Giomo, Riccardo Birello, Elisa Cimetta, Roberto Tozzi, Gaya Spolverato, Marco Agostini

Gels · 20.11.2026 · 12 (11) · 1055

DOI: 10.3390/gels12111055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gels, online erschienen am 20.11.2026. Verfasst von Francesca Sensi und 10 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AIRC Foundation, Fondazione Istituto di Ricerca Pediatrica Città della Speranza, University of Padova.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High-grade serous ovarian carcinoma (HGSOC) lacks biomimetic 3D models that accurately replicate the native extracellular matrix (ECM) microenvironment. Here, we developed a novel tissue-specific ovarian cancer hydrogel (OCH) derived from human HGSOC surgical specimens via an optimized detergent-enzymatic treatment and self-assembly workflow. Quantitative analysis demonstrated effective decellularization with a 98.8% reduction in DNA content while preserving essential structural ECM components, including laminin, collagen I and collagen IV. Second harmonic generation (SHG) and scanning electron microscopy (SEM) confirmed the preservation of an isotropic, highly porous fibrillar collagen architecture. The resulting 3% (w/v) OCH undergoes rapid thermal gelation under physiological conditions (t1/2 = 6.2 min), exhibiting a high swelling capacity, homogeneous molecular transport properties (spatially uniform dextran diffusion), and local mechanical stiffness comparable to a commercial hydrogel. Encapsulated OVCAR3 cells established intimate cell–ECM interactions and exhibited high cytocompatibility alongside sustained long-term proliferation (74.8% of Ki67+ cells). Notably, OVCAR3 cells cultured within the OCH exhibited significantly reduced sensitivity to doxorubicin compared with those cultured in a commercially available hydrogel, highlighting the potential contribution of the patient-derived tumor extracellular matrix to chemotherapy resistance. Overall, OCHs provide a human tumor-derived, tissue-specific 3D model of ovarian cancer, representing a promising organotypic platform for drug screening and translational cancer research.

Förderung

  • AIRC Foundation
  • Fondazione Istituto di Ricerca Pediatrica Città della Speranza
  • University of Padova

Zitieren

APA

Sensi, F., D’Angelo, E., Franchi, C., Castillo, A. A. M., Guerriero, A., Giomo, M., Birello, R., Cimetta, E., Tozzi, R., Spolverato, G., & Agostini, M. (2026). An Organotypic Patient-Derived Ovarian Tumor Extracellular Matrix Hydrogel for Biomimetic 3D Cancer Modeling. Gels, 12(11), 1055. https://doi.org/10.3390/gels12111055

Vancouver

Sensi F, D’Angelo E, Franchi C, Castillo AAM, Guerriero A, Giomo M, et al. An Organotypic Patient-Derived Ovarian Tumor Extracellular Matrix Hydrogel for Biomimetic 3D Cancer Modeling. Gels. 2026;12(11):1055. doi:10.3390/gels12111055

BibTeX
@article{Sensi2026,
  author = {Sensi, Francesca and D’Angelo, Edoardo and Franchi, Caterina and Castillo, Astrid Alexa Mollo and Guerriero, Angela and Giomo, Monica and Birello, Riccardo and Cimetta, Elisa and Tozzi, Roberto and Spolverato, Gaya and Agostini, Marco},
  title = {An Organotypic Patient-Derived Ovarian Tumor Extracellular Matrix Hydrogel for Biomimetic 3D Cancer Modeling},
  journal = {Gels},
  year = {2026},
  volume = {12},
  number = {11},
  pages = {1055},
  doi = {10.3390/gels12111055}
}
Kostenlos starten →